Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well cytarabine with or without SCH 900776 works
in treating adult patients with relapsed acute myeloid leukemia. Drugs used in chemotherapy,
such as cytarabine, work in different ways to stop the growth of cancer cells, either by
killing the cells or stopping them from dividing. SCH 900776 may stop the growth of cancer
cells by blocking some of the enzymes needed for cell growth. It is not yet known whether
cytarabine is more effective with or without SCH 900776 in treating acute myeloid leukemia.